OR2AL1P

Across TCGA pan-cancer cohorts, OR2AL1P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR2AL1P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher OR2AL1P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR2AL1P expression acts as an unfavorable survival marker.

SKCM, STAD, and TGCT are the cancer types where OR2AL1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.063	0.731	<.001	99	view →
STAD	OS	Tertile	III,IV	0.173	0.557	<.001	54	view →
TGCT	DFS	Tertile	II,III,IV	0.015	0.919	<.001	54	view →
THCA	DFS	Tertile	II,III,IV	0.145	0.794	.001	36	view →
ACC	DFS	Tertile	II,III,IV	0.242	0.724	.034	18	view →
ESCA	DFS	Tertile	II,III,IV	0.131	0.776	.043	9	view →
LGG	DFS	Tertile	All	0.224	0.728	.025	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

OR2AL1P–SKCM (DFS)

Open the SKCM breakdown →